Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.
Other companies in bioAffinity Technologies’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP) and Entero Therapeutics (NASDAQ:ENTO).
There is no analysis for bioAffinity Technologies to provide a consensus price target.
The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $2.17 last updated November 11, 2025 at 6:49 PM EST.
There are no upcoming dividends for bioAffinity Technologies.
bioAffinity Technologies’s Q3 earnings are confirmed for Tuesday, November 25, 2025.
There is no upcoming split for bioAffinity Technologies.
bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.